3.215
price up icon0.94%   0.015
 
loading

Finanzdaten der Tharimmune Inc-Aktie (THAR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
27.31%
1.8512
2.5467 3.8475 3.8656 2.3735
Operating Income/Loss
27.31%
-1.8512
-2.5467 -3.8475 -3.8656 -2.3735
Nonoperating Income/Loss
180.42%
-0.00399
0.00497 0.0269 0.0697 0.0484
Income/Loss From Continuing Operations Before Tax
27.01%
-1.8552
-2.5417 -3.8206 -3.7959 -2.3251
Income/Loss From Continuing Operations After Tax
27.01%
-1.8552
-2.5417 -3.8206 -3.7959 -2.3251
Net Income/Loss
27.01%
-1.8552
-2.5417 -3.8206 -3.7959 -2.3251
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
11.84%
2.8773
2.5727 0.1631 1.5473 0.9621
Diluted Average Shares
11.84%
2.8773
2.5727 0.1631 1.5473 0.9621
Basic Earnings Per Share
35.35%
-0.64
-0.99 -2.02 -2.45 -2.42
Diluted Earnings Per Share
35.35%
-0.64
-0.99 -2.02 -2.45 -2.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.72
price up icon 1.13%
$28.98
price up icon 0.77%
$101.98
price up icon 0.38%
$104.38
price up icon 0.39%
biotechnology ONC
$310.18
price down icon 0.49%
$183.80
price down icon 1.37%
Kapitalisierung:     |  Volumen (24h):